Period:
Draw Mode:
| Volume | 641,648 |
|
|||||
| News | - | ||||||
| Day High | 39.85 | Low High |
|||||
| Day Low | 39.24 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Qiagen NV | QGEN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.07 | -0.18% | 39.54 | 14:50:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 39.60 | 39.24 | 39.85 | 39.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,562 | 641,648 | $ 39.49 | $ 25,336,031 | - | 38.98 - 51.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:51:00 | 1 | $ 39.53 | USD |
Qiagen NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9B | 227.72M | - | 2.14B | 575.66M | 2.53 | 10.18 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Qiagen NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 40.39 | 40.97 | 38.98 | 39.72 | 978,352 | -0.85 | -2.1% |
| 1 Month | 46.04 | 46.25 | 38.98 | 41.75 | 1,218,644 | -6.50 | -14.12% |
| 3 Months | 45.07 | 47.70 | 38.98 | 44.12 | 1,267,456 | -5.53 | -12.27% |
| 6 Months | 46.41 | 47.70 | 38.98 | 44.76 | 1,100,056 | -6.87 | -14.8% |
| 1 Year | 41.22 | 51.18 | 38.98 | 45.43 | 990,512 | -1.68 | -4.08% |
| 3 Years | 52.41 | 59.00 | 38.98 | 48.21 | 882,471 | -12.87 | -24.56% |
| 5 Years | 37.43 | 59.00 | 24.80 | 42.86 | 1,155,085 | 2.11 | 5.64% |
Qiagen NV Description
| Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%). |